Identity
- Security key
- 17809
- Ticker
- KPTI
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2013-11-06
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- KPTI
Detail
Enriched 2026-08-14 20:47
- Market cap
- $46,005,774.29
- Shares outstanding (class)
- 22,662,943
- Shares outstanding (weighted)
- 22,662,943
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 228
- Location
- NEWTON, MA
- Homepage
- https://www.karyopharm.com
- Description
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).